Terms: = Gastric cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Staging
41 results:
1. The role of mir96 in predicting CTC status and prognostic evaluation in gastric cancer patients.
Zheng Q; Ge H
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):264-274. PubMed ID: 38430012
[TBL] [Abstract] [Full Text] [Related]
2. TRIP 13-dependent pathways promote the development of gastric cancer.
Ni F; Liu X; Xia Y; Zhu H; Li F; Zhang N; Xu H
Funct Integr Genomics; 2023 Jul; 23(3):232. PubMed ID: 37432513
[TBL] [Abstract] [Full Text] [Related]
3. Confusion and prospects for carcinogenesis of gastric adenoma and dysplasia: What is the correct answer currently?
Kinami S; Yamada S; Takamura H
World J Gastroenterol; 2022 Dec; 28(48):6900-6908. PubMed ID: 36632315
[TBL] [Abstract] [Full Text] [Related]
4. CRISPR/Cas9-mediated knockout of SGLT1 inhibits proliferation and alters metabolism of gastric cancer cells.
Shi M; Wang C; Ji J; Cai Q; Zhao Q; Xi W; Zhang J
Cell Signal; 2022 Feb; 90():110192. PubMed ID: 34774990
[TBL] [Abstract] [Full Text] [Related]
5. Relationship between HER-2, COX-2, p53 and clinicopathologic features in gastric adenocarcinoma. Do these biomarkers have any prognostic significance?
Ugraş N; Özgün G; Ocakoğlu G; Yerci Ö; Öztürk E
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():176-81. PubMed ID: 25910300
[TBL] [Abstract] [Full Text] [Related]
6. Biological prognostic parameters in gastric carcinomas.
Potecă T; Potecă A; Sajin M; Comănescu M
Chirurgia (Bucur); 2014; 109(3):347-54. PubMed ID: 24956340
[TBL] [Abstract] [Full Text] [Related]
7. New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee.
Sawada T; Yashiro M; Sentani K; Oue N; Yasui W; Miyazaki K; Kai K; Fushida S; Fujimura T; Ohira M; Kakeji Y; Natsugoe S; Shirabe K; Nomura S; Shimada Y; Tomita N; Hirakawa K; Maehara Y
Gastric Cancer; 2015 Jan; 18(1):119-28. PubMed ID: 24488015
[TBL] [Abstract] [Full Text] [Related]
8. Analysis of SEMA3B methylation and expression patterns in gastric cancer tissue and cell lines.
Chen R; Zhuge X; Huang Z; Lu D; Ye X; Chen C; Yu J; Lu G
Oncol Rep; 2014 Mar; 31(3):1211-8. PubMed ID: 24402303
[TBL] [Abstract] [Full Text] [Related]
9. The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients.
Liu X; Cai H; Huang H; Long Z; Shi Y; Wang Y
PLoS One; 2011; 6(12):e29670. PubMed ID: 22216342
[TBL] [Abstract] [Full Text] [Related]
10. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of p73 as a tissue marker for high-risk gastritis.
Carrasco G; Diaz J; Valbuena JR; Ibanez P; Rodriguez P; Araya G; Rodriguez C; Torres J; Duarte I; Aravena E; Mena F; Barrientos C; Corvalan AH
Clin Cancer Res; 2010 Jun; 16(12):3253-9. PubMed ID: 20530692
[TBL] [Abstract] [Full Text] [Related]
12. Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions.
Lehrbach DM; Cecconello I; Ribeiro U; Capelozzi VL; Ab'saber AM; Alves VA
Arq Gastroenterol; 2009; 46(4):315-20. PubMed ID: 20232013
[TBL] [Abstract] [Full Text] [Related]
13. The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.
Zheng HC; Zheng YS; Xia P; Xu XY; Xing YN; Takahashi H; Guan YF; Takano Y
Histol Histopathol; 2010 Apr; 25(4):445-52. PubMed ID: 20183797
[TBL] [Abstract] [Full Text] [Related]
14. [Differential expression of immunohistochemical markers between cardiac carcinoma and carcinoma in antrum of stomach and correlation thereof with clinicopathological factors].
Ye YW; Shi YQ; Wang CM; Li BZ; Zhu L
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(14):962-6. PubMed ID: 19671307
[TBL] [Abstract] [Full Text] [Related]
15. Signet ring cell adenocarcinoma of the oropharynx: presentation of a rare case and review of the literature.
Veit JA; Reichelt U; Tesche S
Auris Nasus Larynx; 2009 Dec; 36(6):717-20. PubMed ID: 19446973
[TBL] [Abstract] [Full Text] [Related]
16. FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging.
Ji F; Jin X; Jiao CH; Xu QW; Wang ZW; Chen YL
World J Gastroenterol; 2009 May; 15(18):2228-33. PubMed ID: 19437562
[TBL] [Abstract] [Full Text] [Related]
17. Artificial neural network-based study can predict gastric cancer staging.
Lai KC; Chiang HC; Chen WC; Tsai FJ; Jeng LB
Hepatogastroenterology; 2008; 55(86-87):1859-63. PubMed ID: 19102409
[TBL] [Abstract] [Full Text] [Related]
18. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
[TBL] [Abstract] [Full Text] [Related]
19. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
[TBL] [Abstract] [Full Text] [Related]
20. The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China.
Qiu LL; Hua PY; Ye LL; Wang YC; Qiu T; Bao HZ; Wang L
Cancer Detect Prev; 2007; 31(1):45-9. PubMed ID: 17292563
[TBL] [Abstract] [Full Text] [Related]
[Next]
